Abstract Rationale: Coronavirus disease 2019 (COVID-19) is a novel infectious disease and became a global issue. Treatment of COVID-19 especially in solid organ transplant recipients is empirical and controversial, especially the adjustment of the immunosuppressants. Patient concerns: A 29-year-old kidney transplant recipient with the symptoms of COVID-19 pneumonia. Diagnoses: COVID-19 pneumonia after kidney transplantation. Interventions: He was treated with modified immunosuppressants (unchanged dose of tacrolimus and oral corticosteroids while discontinuing mycophenolate mofetil (MMF)), antibiotics, interferon α-2b inhalation and traditional Chinese medicine. Outcomes: He recovered from COVID-19 pneumonia after 29 days of hospitalization. And the renal function (measured as blood urea nitrogen, serum creatinine, and urine protein) returned to normal. Lessons: In certain group of COVID-19 (e.g., mild to moderate cases, young patients without comorbidities), a reduction instead of an overall withdrawal of immunosuppressant in kidney transplant recipients is feasible.
【저자키워드】 COVID-19, Traditional Chinese medicine, renal function, Kidney transplantation, Immunosuppressant, 【초록키워드】 Corticosteroid, Coronavirus disease 2019, Hospitalization, Pneumonia, Comorbidities, interferon, Antibiotics, Infectious disease, Withdrawal, immunosuppressants, kidney, Protein, Patient, Urine, Mild, moderate, kidney transplant, solid organ transplant, kidney transplant recipient, dose, reduction, Blood urea nitrogen, serum creatinine, Chinese, symptoms of COVID-19, recipient, treated, feasible, returned, 【제목키워드】 Case report, kidney transplant, with COVID-19,